Douglas S. Ingram

Insider Reports History

Entity
Individual
Location
2525 Dupont Dr, Irvine, CA
Signature
/s/ Brian Adams, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas S. Ingram:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. President & CEO, Director Common Stock 390K $31.4M $80.34 Nov 3, 2023 Direct
Relay Therapeutics, Inc. Director Stock Option (Right to Buy) 102K Jun 3, 2024 Direct

Insider Reports Filed by Douglas S. Ingram

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RLAY Relay Therapeutics, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Director
SRPT Sarepta Therapeutics, Inc. Nov 3, 2023 4 $2M 4 Nov 6, 2023 President & CEO, Director
RLAY Relay Therapeutics, Inc. May 31, 2023 1 $0 4 Jun 1, 2023 Director
RLAY Relay Therapeutics, Inc. May 27, 2022 1 $0 4 May 27, 2022 Director
SRPT Sarepta Therapeutics, Inc. Nov 17, 2021 1 $2M 4 Nov 17, 2021 President & CEO, Director
SRPT Sarepta Therapeutics, Inc. Jun 26, 2021 1 -$1.43M 4 Jun 28, 2021 President & CEO, Director
RLAY Relay Therapeutics, Inc. May 19, 2021 1 $0 4 May 21, 2021 Director